ASX:WHC
ASX:WHCOil and Gas

Will Whitehaven Coal’s (ASX:WHC) Buy-Back Activity Shape Its Investment Story?

Earlier this week, Whitehaven Coal Limited announced it has repurchased a total of 7,456,220 ordinary fully paid securities under its ongoing on-market buy-back program as of November 12, 2025. This share buy-back reflects management’s focus on capital management and can be interpreted as a signal of confidence in the company’s financial position. We will examine how the continued share buy-back activity may influence Whitehaven Coal’s broader investment narrative and outlook. Trump has...
ASX:CGS
ASX:CGSHealthcare Services

Exploring 3 Promising Undervalued Small Caps In Global With Insider Action

In recent weeks, global markets have faced a mix of challenges, including a tech-driven sell-off in U.S. stocks and the longest federal government shutdown on record, which has weighed heavily on investor sentiment. Despite these headwinds, small-cap stocks present intriguing opportunities for investors seeking growth potential amid broader market volatility. Identifying promising small-cap stocks often involves looking at companies with strong fundamentals that can weather economic...
ASX:XRO
ASX:XROSoftware

Xero (ASX:XRO) Valuation in Focus Following Strong Half-Year Earnings Results

Xero (ASX:XRO) just released its half-year earnings, revealing a clear uptick in both revenue and net income compared to last year. Investors are watching closely. These results give a snapshot of the company’s momentum. See our latest analysis for Xero. Despite delivering robust growth in both revenue and net income, Xero’s 1-day share price return fell 9.03% following the results, extending its recent slide to a 12.39% drop over the week. While long-term investors are still ahead with an...
ASX:RHC
ASX:RHCHealthcare

Can Ramsay Health Care’s (ASX:RHC) Cost Discipline Counter Long-Term Funding and Inflation Pressures?

Recently, Ramsay Santé, the European subsidiary of Ramsay Health Care, reported that for the quarter ended September 2025, revenue rose by 2.6% and EBITDA increased by 6.5%, despite funding cuts and cost inflation challenges. This performance was largely achieved through activity growth, disciplined cost management, and the expansion of care models and facilities in France, Sweden, and Norway, aligning services to evolving patient needs. We will explore how Ramsay Santé's resilience in the...
ASX:WBC
ASX:WBCBanks

Westpac (ASX:WBC) Valuation in Focus After Share Buyback Extension and Dividend Increase

Westpac Banking (ASX:WBC) has extended its share buyback program by a year and announced a higher ordinary dividend for the recent half, with key ex-dividend and payment dates approaching. These updates highlight management's ongoing focus on shareholder returns. See our latest analysis for Westpac Banking. Westpac Banking’s active share buyback and stronger dividend appear to be fueling renewed confidence in the stock. The 2025 year-to-date share price return stands at an impressive 21.69%...
ASX:PTN
ASX:PTNMetals and Mining

ASX Penny Stocks To Watch In November 2025

The Australian market is facing a challenging period, with the ASX 200 futures indicating a significant drop following recent U.S. economic disruptions and domestic political shifts affecting investor sentiment. Despite these hurdles, opportunities still exist for investors willing to explore less conventional avenues such as penny stocks. Although the term 'penny stocks' might seem outdated, these smaller or newer companies can offer unique growth potential when backed by strong financials;...
ASX:PME
ASX:PMEHealthcare Services

Pro Medicus (ASX:PME): How US Contract Momentum Shapes Its Current Valuation

Pro Medicus (ASX:PME) has made headlines by clinching three major US hospital contracts in just four months. This achievement has already tripled its contract win rate from last year and sparked fresh curiosity among investors. See our latest analysis for Pro Medicus. Despite some recent share price volatility, including a 10.98% dip over the past month, Pro Medicus is still up 24.96% on a total shareholder return basis for the past year and has delivered a remarkable 336% over three years...
ASX:PLS
ASX:PLSMetals and Mining

Pilbara Minerals (ASX:PLS) Valuation in Focus Following Lithium Price Surge and Share Rally

Pilbara Minerals (ASX:PLS) shares are attracting attention following a surge in lithium prices, as supply disruptions and rising demand from electric vehicles fuel optimism for major producers in the sector. See our latest analysis for Pilbara Minerals. Pilbara Minerals has enjoyed a powerful rebound lately, with a 1-month share price return of 41.6% and an even sharper 71% gain so far in 2025. Renewed optimism in lithium prices and tight supply have driven this momentum. While short-term...
ASX:DRR
ASX:DRRMetals and Mining

Did Deterra Royalties' (ASX:DRR) CEO Transition Reset Its Leadership Vision for Investors?

Deterra Royalties Limited recently announced that its founding Managing Director and CEO, Julian Andrews, will step down for personal reasons by the end of 2025, with Non-executive Director Jason Neal appointed as interim CEO while the executive search is underway. This leadership change comes as Deterra prepares for a key investor conference presentation, underscoring a period of transition at the top of Australia's leading mining royalty enterprise with global operations. We'll explore how...
ASX:DRO
ASX:DROAerospace & Defense

Why DroneShield (ASX:DRO) Is Down 33.8% After Executive Share Sales and Contract Clarification

Earlier this week, DroneShield disclosed that its CEO, chairman, and a director sold a significant number of shares, following clarification that a previously announced A$7.6 million contract win was not new business but a reissue. This combination of insider selling and contract withdrawal sparked widespread investor attention and raised questions about executive confidence and the transparency of the company's sales pipeline. We'll explore how this wave of insider share sales and contract...